Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.49 |
| ▸ | PPARD | Q03181 | 7/20 | 0.49 |
| ▸ | PPARA | Q07869 | 7/20 | 0.49 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.47 |
| ▸ | CPT1A | P50416 | 7/20 | 0.46 |
| ▸ | CPT1B | Q92523 | 7/20 | 0.46 |
| ▸ | CPT2 | P23786 | 5/20 | 0.46 |
| ▸ | ALB | P02768 | 2/20 | 0.43 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833907 | 0.89 | PPARG (0.57) | PPARGPPARDPPARAALB | |
| SCHEMBL6357406 | 0.86 | CPT1A (0.54) | PPARGPPARDPPARADNMT3ACPT1A | |
| SCHEMBL6359987 | 0.84 | PPARG (0.65) | PPARGPPARDPPARACPT1ACPT1B | |
| SCHEMBL6353169 | 0.82 | CPT1A (0.53) | PPARGPPARDPPARADNMT3ACPT1A | |
| SCHEMBL6351726 | 0.81 | MAPT (0.50) | PPARGPPARDPPARADNMT3ACPT1A | |
| SCHEMBL6830627 | 0.81 | CPT1A (0.46) | PPARGPPARDPPARADNMT3ACPT1A | |
| SCHEMBL6813966 | 0.79 | SERPINE1 (0.52) | PPARGPPARDPPARADNMT3AALB | |
| SCHEMBL15788196 | 0.79 | MAPT (0.61) | PPARGPPARDPPARA | |
| SCHEMBL6351997 | 0.79 | CPT2 (0.48) | PPARGPPARDPPARADNMT3ACPT1A | |
| SCHEMBL6351239 | 0.77 | PPARG (0.65) | PPARGPPARDPPARAALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | PPARG 285/4885PPARD 123/4885PPARA 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.